Medtronic Derivative Assets and Liabilities, Net, Collateral, Obligation to Return Cash decreased by 32.2% to -$115.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 142.4%, from $271.00M to -$115.00M. Over 5 years (FY 2020 to FY 2025), Derivative Assets and Liabilities, Net, Collateral, Obligation to Return Cash shows a downward trend with a 38.6% CAGR.
other_derivative_assetsand_liabilities_net_collateral_ob_367c35| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$46.00M | -$25.00M | -$27.00M | $18.00M | $254.00M | $531.00M | $703.00M | $41.00M | $11.00M | $5.00M | $170.00M | $29.00M | $101.00M | $92.00M | $52.00M | $271.00M | -$125.00M | -$194.00M | -$87.00M | -$115.00M |
| QoQ Change | — | +45.7% | -8.0% | +166.7% | >999% | +109.1% | +32.4% | -94.2% | -73.2% | -54.5% | >999% | -82.9% | +248.3% | -8.9% | -43.5% | +421.2% | -146.1% | -55.2% | +55.2% | -32.2% |
| YoY Change | — | — | — | — | +652.2% | >999% | >999% | +127.8% | -95.7% | -99.1% | -75.8% | -29.3% | +818.2% | >999% | -69.4% | +834.5% | -223.8% | -310.9% | -267.3% | -142.4% |